Joep Joosten, theme Infectious diseases and global health, and colleagues determined the composition of PIWI protein complexes to provide novel insights into the piRNA pathway. They published this recently in Cell reports.
Aedes aegypti mosquitoes are responsible for the transmission of arthropod-borne (arbo)viruses which may cause debilitating diseases such as dengue and zika. As arboviruses need to replicate within the mosquito in order to be transmitted to a new human host, the mosquito antiviral immune response is critically important in determining arboviral disease burden. In recent years, a novel antiviral pathway has been discovered in mosquitoes, which is based on the recognition of viral RNA by small RNAs called PIWI-interacting (pi)RNAs. The research group of Ronald van Rij (dept. Medical Microbiology) has spearheaded efforts to uncover the molecular mechanisms and functions of the mosquito piRNA pathway.
In their most recent paper, which was published in Cell Reports this week, Joep Joosten and colleagues determined the composition of PIWI protein complexes to provide novel insights into the piRNA pathway. Joosten: “In collaboration with the lab of Michiel Vermeulen, we performed comprehensive proteomics to identify PIWI protein interactors. Using these data, we uncovered two new components of the mosquito piRNA machinery: Pasilla and a protein we termed Atari. Pasilla has previously been described to be an important regulator of alternate splicing, yet, in mosquitoes, a cytoplasmic Pasilla isoform is expressed that is crucial for the production of piRNAs.
The second piRNA pathway component that we characterized, Atari, provides a platform for RNA substrates and PIWI proteins to generate and amplify piRNA molecules. As this amplification process is termed ‘ping-pong amplification’, we decided to name the gene Atari, after the platform on which the arcade game pong was first released. Aside from discovering two previously unknown components of the piRNA machinery, our proteomics data provides a wealth of information to inform further follow-up studies.”
Related news items
New ultra-high field MRI system available for Radboudumc and Radboud University10 June 2021
Recently, the Hahn institute in Essen has received a new heart: a 20-ton ultra-high-field MRI scanner from Siemens Healthcare with a magnetic field strength of 7 Tesla. The new CE-approved scanner is ready for business, and projects on body and brain imaging are starting up.read more
On the prevalence of cerebral amyloid angiopathy a systematic review and meta-analysis10 June 2021
Published in ‘Alzheimers and Dementia’, researchers at Radboudumc performed a systematic review and meta-analysis on the prevalence of Cerebral Amyloid Angiopathy. They scrutinized and analyzed 170 publications, comprising publications using either a neuroimaging or a neuropathological approach.read more
Retina-on-chip modeling and treating eye diseases in a dish10 June 2021
Alex Garanto, together with Anneke den Hollander and Andries van der Meer (UTwente) have received 1,17M€ to develop a retina-on-chip model to improve our understanding in eye diseases and to develop treatments against them.read more
A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses8 June 2021
Jeroen Creemers and Johannes Textor published in the Journal for ImmunoTherapy of Cancer that a tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery.read more
New method to prevent ovarian cancer increases quality of life8 June 2021
Researchers at Radboudumc have shown that quality of life is better in women with a BRCA1 or BRCA2 mutation after fallopian tube removal with delayed ovarian removal to prevent ovarian cancer.read more